CCR6 and neoplasm: Targeting CCR6 on tumor cells may be a potential strategy for inhibiting CRC metastasis by enhancing the efficacy of immune checkpoint inhibitors, but further research is needed to fully understand the role of CCR6 in CRC and its metastasis.